Selective Serotonin Reuptake Inhibitors

Antidepressants are medicines used to help people who have depression. Selective Serotonin Reuptake Inhibitors (SSRIs) are members of a group of antidepressants that includes drugs such as citalopram (brand name of Celexa), fluoxetine (brand name of Prozac), paroxetine (brand name of Paxil) and sertraline (brand name of Zoloft).

Follow the links below to find information about selective serotonin reuptake inhibitors (SSRIs).

Updated May 2011

 

Printer friendly page Printer friendly page

Related HealthInsite Topics

Systematic Reviews of Selective Serotonin Reuptake Inhibitors

HealthInsite Topic Page
Links to systematic reviews of the evidence for the effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs).

13 Resources Found

Results 1 to 13 displayed.

Title:   Citalopram and heart problems - changes to recommended doses
Publisher:   Australian Government Department of Health and Ageing
Description:   The TGA is advising that citalopram should no longer be used at doses greater than 40 mg per day.
Date:   Nov 2011
Title:   New drugs - Palonosetron hydrochloride
Publisher:   Australian Prescriber
Description:   Some of the views expressed in the following notes on newly approved products should be regarded as tentative, as there may have been limited published data and little experience in Australia of their safety or efficacy.
Date:   Aug 2011
Title:   Release of the Report of the Psychiatric Drug Safety Expert Advisory Panel
Publisher:   Australian Government Department of Health and Ageing
Description:   In August 2008 the TGA established an independent panel of psychiatrists and epidemiologists to undertake a specific review of selective serotonin reuptake inhibitors (SSRIs) and atypical antipsychotic medicines.
Date:   Dec 2009
Title:   Selective serotonin reuptake inhibitors (SSRIs) for depression - myDr.com.au
Publisher:   myDr
Description:   Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed type of antidepressant medicines.
Date:   Mar 2009
Title:   Antidepressants for the treatment of depression in children and young people - a fact sheet for GPs
Publisher:   beyondblue
Description:   Depression is a common condition that affects people of all ages, including children and young people. It is also a serious condition, associated with significant impairment, disability and death from suicide. Effective treatments are available and prompt intervention is important.
Date:   Mar 2009
Title:   Fact sheet for young people - antidepressants for the treatment of depression in children and adolescents
Publisher:   beyondblue
Description:   While antidepressant medicines have been used to treat young people under 18 years with more severe depression, there is much debate among doctors as to the benefits of these medicines with young people. One of the main reasons why doctors have found it difficult to give clear recommendations is because of the lack of research on the impact of antidepressants with young people.
Date:   Mar 2008
Title:   Antidepressants in pregnancy and breastfeeding
Publisher:   Australian Prescriber
Description:   Clinicians must consider the risk of damage from the medications and the effects of the illness itself on both the mother and the baby.
Date:   Oct 2007
Title:   Children, serotonin and suicide
Publisher:   Australian Prescriber
Description:   Controlled trials show that psychosocial treatments are effective in mild to moderate paediatric depression. However effectiveness in severe depression is questionable. This raises the question of drug treatment
Date:   Oct 2005
Title:   Information for health professionals concerning use of SSRI antidepressants in pregnant women
Publisher:   Australian Government Department of Health and Ageing
Description:   New information has recently become available that suggests pregnant women who take SSRI antidepressant medicines in early pregnancy may have an increased risk of giving birth to an infant with a heart problem.
Date:   Sep 2005
Title:   General information concerning use of SSRI antidepressants in pregnant women
Publisher:   Australian Government Department of Health and Ageing
Description:   New information has recently become available that suggests pregnant women who take SSRI antidepressant medicines in early pregnancy may have an increased risk of giving birth to an infant with a heart problem.
Date:   Sep 2005
Title:   Advice for women taking paroxetine intending to become pregnant or in early pregnancy
Publisher:   Australian Government Department of Health and Ageing
Description:   There is some information to suggest that use of the medicine paroxetine in early pregnancy (first 13 weeks) may be associated with an increased risk of some congenital malformations in babies. It is not proven that this does occur.
Date:   Jul 2005
Title:   Use of SSRI antidepressants in children and adolescents
Publisher:   Australian Government Department of Health and Ageing
Description:   The Australian Adverse Drug Reactions Advisory Committee (ADRAC) has considered the safety and efficacy of the Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in children and adolescents
Date:   Mar 2004
Title:   The new antidepressants - mechanisms of action
Publisher:   Australian Prescriber
Description:   Citalopram, fluvoxamine, nefazodone and venlafaxine have recently been introduced into Australian clinical practice. The first two drugs are selective serotonin reuptake inhibitors, while the others have different acute pharmacological effects.
Date:   Oct 1999

Results 1 to 13 displayed.